United Royale Holdings Corp. (URYL) Stock Competitors & Peer Comparison
See (URYL) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Farm Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| URYL | $0.00 | +0.00% | 15.1K | N/A | N/A | N/A |
| WLMIF | $2.90 | +9.02% | 16.6B | 11.57 | $0.23 | +4.11% |
| WLMIY | $26.22 | +0.92% | 16.4B | 11.61 | $2.26 | +4.22% |
| MNHVF | $20.10 | -8.18% | 10.6B | 10.69 | $1.88 | +3.06% |
| MHGVY | $19.92 | +1.08% | 10.6B | 10.70 | $1.87 | +3.51% |
| SALRF | $55.50 | +0.00% | 7.5B | 34.05 | $1.63 | +3.52% |
| SALRY | $13.59 | +0.48% | 7.4B | 33.20 | $0.41 | +4.00% |
| KLKBF | $6.17 | +0.00% | 6.8B | 11.43 | $0.54 | +2.41% |
| PPOKF | $0.39 | +57.20% | 6.4B | 19.65 | $0.02 | +2.54% |
| CPOUF | $0.75 | +7.14% | 5.7B | 7.50 | $0.10 | +5.16% |
Stock Comparison
URYL vs WLMIF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, WLMIF has a market cap of 16.6B. Regarding current trading prices, URYL is priced at $0.00, while WLMIF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas WLMIF's P/E ratio is 11.57. In terms of profitability, URYL's ROE is -4.37%, compared to WLMIF's ROE of +0.04%. Regarding short-term risk, URYL and WLMIF have similar daily volatility (0.00).Check WLMIF's competition here
URYL vs WLMIY Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, WLMIY has a market cap of 16.4B. Regarding current trading prices, URYL is priced at $0.00, while WLMIY trades at $26.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas WLMIY's P/E ratio is 11.61. In terms of profitability, URYL's ROE is -4.37%, compared to WLMIY's ROE of +0.04%. Regarding short-term risk, URYL is less volatile compared to WLMIY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check WLMIY's competition here
URYL vs MNHVF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, MNHVF has a market cap of 10.6B. Regarding current trading prices, URYL is priced at $0.00, while MNHVF trades at $20.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas MNHVF's P/E ratio is 10.69. In terms of profitability, URYL's ROE is -4.37%, compared to MNHVF's ROE of +0.21%. Regarding short-term risk, URYL is less volatile compared to MNHVF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check MNHVF's competition here
URYL vs MHGVY Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, MHGVY has a market cap of 10.6B. Regarding current trading prices, URYL is priced at $0.00, while MHGVY trades at $19.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas MHGVY's P/E ratio is 10.70. In terms of profitability, URYL's ROE is -4.37%, compared to MHGVY's ROE of +0.21%. Regarding short-term risk, URYL is less volatile compared to MHGVY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check MHGVY's competition here
URYL vs SALRF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SALRF has a market cap of 7.5B. Regarding current trading prices, URYL is priced at $0.00, while SALRF trades at $55.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SALRF's P/E ratio is 34.05. In terms of profitability, URYL's ROE is -4.37%, compared to SALRF's ROE of +0.12%. Regarding short-term risk, URYL and SALRF have similar daily volatility (0.00).Check SALRF's competition here
URYL vs SALRY Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SALRY has a market cap of 7.4B. Regarding current trading prices, URYL is priced at $0.00, while SALRY trades at $13.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SALRY's P/E ratio is 33.20. In terms of profitability, URYL's ROE is -4.37%, compared to SALRY's ROE of +0.12%. Regarding short-term risk, URYL is less volatile compared to SALRY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check SALRY's competition here
URYL vs KLKBF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, KLKBF has a market cap of 6.8B. Regarding current trading prices, URYL is priced at $0.00, while KLKBF trades at $6.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas KLKBF's P/E ratio is 11.43. In terms of profitability, URYL's ROE is -4.37%, compared to KLKBF's ROE of +0.08%. Regarding short-term risk, URYL and KLKBF have similar daily volatility (0.00).Check KLKBF's competition here
URYL vs PPOKF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, PPOKF has a market cap of 6.4B. Regarding current trading prices, URYL is priced at $0.00, while PPOKF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas PPOKF's P/E ratio is 19.65. In terms of profitability, URYL's ROE is -4.37%, compared to PPOKF's ROE of +0.20%. Regarding short-term risk, URYL and PPOKF have similar daily volatility (0.00).Check PPOKF's competition here
URYL vs CPOUF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CPOUF has a market cap of 5.7B. Regarding current trading prices, URYL is priced at $0.00, while CPOUF trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CPOUF's P/E ratio is 7.50. In terms of profitability, URYL's ROE is -4.37%, compared to CPOUF's ROE of +0.09%. Regarding short-term risk, URYL is less volatile compared to CPOUF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check CPOUF's competition here
URYL vs KLKBY Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, KLKBY has a market cap of 5.6B. Regarding current trading prices, URYL is priced at $0.00, while KLKBY trades at $5.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas KLKBY's P/E ratio is 22.95. In terms of profitability, URYL's ROE is -4.37%, compared to KLKBY's ROE of +0.08%. Regarding short-term risk, URYL and KLKBY have similar daily volatility (0.00).Check KLKBY's competition here
URYL vs CHPFF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CHPFF has a market cap of 5.3B. Regarding current trading prices, URYL is priced at $0.00, while CHPFF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CHPFF's P/E ratio is 7.88. In terms of profitability, URYL's ROE is -4.37%, compared to CHPFF's ROE of +0.09%. Regarding short-term risk, URYL and CHPFF have similar daily volatility (0.00).Check CHPFF's competition here
URYL vs FTROF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, FTROF has a market cap of 3.5B. Regarding current trading prices, URYL is priced at $0.00, while FTROF trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas FTROF's P/E ratio is 9.83. In terms of profitability, URYL's ROE is -4.37%, compared to FTROF's ROE of +0.15%. Regarding short-term risk, URYL is less volatile compared to FTROF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check FTROF's competition here
URYL vs FSRCY Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, FSRCY has a market cap of 2.9B. Regarding current trading prices, URYL is priced at $0.00, while FSRCY trades at $184.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas FSRCY's P/E ratio is 8.04. In terms of profitability, URYL's ROE is -4.37%, compared to FSRCY's ROE of +0.15%. Regarding short-term risk, URYL and FSRCY have similar daily volatility (0.00).Check FSRCY's competition here
URYL vs KNKZF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, KNKZF has a market cap of 2.8B. Regarding current trading prices, URYL is priced at $0.00, while KNKZF trades at $84.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas KNKZF's P/E ratio is 15.37. In terms of profitability, URYL's ROE is -4.37%, compared to KNKZF's ROE of +0.09%. Regarding short-term risk, URYL and KNKZF have similar daily volatility (0.00).Check KNKZF's competition here
URYL vs BKFKF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, BKFKF has a market cap of 2.7B. Regarding current trading prices, URYL is priced at $0.00, while BKFKF trades at $46.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas BKFKF's P/E ratio is 20.81. In terms of profitability, URYL's ROE is -4.37%, compared to BKFKF's ROE of +0.08%. Regarding short-term risk, URYL and BKFKF have similar daily volatility (0.00).Check BKFKF's competition here
URYL vs GARPY Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, GARPY has a market cap of 2.7B. Regarding current trading prices, URYL is priced at $0.00, while GARPY trades at $21.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas GARPY's P/E ratio is 6.66. In terms of profitability, URYL's ROE is -4.37%, compared to GARPY's ROE of +0.06%. Regarding short-term risk, URYL is less volatile compared to GARPY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check GARPY's competition here
URYL vs GARPF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, GARPF has a market cap of 2.7B. Regarding current trading prices, URYL is priced at $0.00, while GARPF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas GARPF's P/E ratio is 7.00. In terms of profitability, URYL's ROE is -4.37%, compared to GARPF's ROE of +0.06%. Regarding short-term risk, URYL and GARPF have similar daily volatility (0.00).Check GARPF's competition here
URYL vs ASTVF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, ASTVF has a market cap of 2.2B. Regarding current trading prices, URYL is priced at $0.00, while ASTVF trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas ASTVF's P/E ratio is 22.00. In terms of profitability, URYL's ROE is -4.37%, compared to ASTVF's ROE of +0.06%. Regarding short-term risk, URYL and ASTVF have similar daily volatility (0.00).Check ASTVF's competition here
URYL vs SLCJY Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SLCJY has a market cap of 1.4B. Regarding current trading prices, URYL is priced at $0.00, while SLCJY trades at $2.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SLCJY's P/E ratio is 22.12. In terms of profitability, URYL's ROE is -4.37%, compared to SLCJY's ROE of +0.06%. Regarding short-term risk, URYL is less volatile compared to SLCJY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check SLCJY's competition here
URYL vs DNDPF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, DNDPF has a market cap of 1.3B. Regarding current trading prices, URYL is priced at $0.00, while DNDPF trades at $14.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas DNDPF's P/E ratio is -35.89. In terms of profitability, URYL's ROE is -4.37%, compared to DNDPF's ROE of -0.12%. Regarding short-term risk, URYL and DNDPF have similar daily volatility (0.00).Check DNDPF's competition here
URYL vs UPBMF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, UPBMF has a market cap of 1.3B. Regarding current trading prices, URYL is priced at $0.00, while UPBMF trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas UPBMF's P/E ratio is 8.04. In terms of profitability, URYL's ROE is -4.37%, compared to UPBMF's ROE of +0.29%. Regarding short-term risk, URYL and UPBMF have similar daily volatility (0.00).Check UPBMF's competition here
URYL vs SISAF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SISAF has a market cap of 1B. Regarding current trading prices, URYL is priced at $0.00, while SISAF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SISAF's P/E ratio is 9.12. In terms of profitability, URYL's ROE is -4.37%, compared to SISAF's ROE of +0.13%. Regarding short-term risk, URYL and SISAF have similar daily volatility (0.00).Check SISAF's competition here
URYL vs MHPSY Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, MHPSY has a market cap of 1B. Regarding current trading prices, URYL is priced at $0.00, while MHPSY trades at $9.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas MHPSY's P/E ratio is 5.92. In terms of profitability, URYL's ROE is -4.37%, compared to MHPSY's ROE of +0.08%. Regarding short-term risk, URYL and MHPSY have similar daily volatility (0.00).Check MHPSY's competition here
URYL vs CTTQF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CTTQF has a market cap of 985.2M. Regarding current trading prices, URYL is priced at $0.00, while CTTQF trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CTTQF's P/E ratio is 70.67. In terms of profitability, URYL's ROE is -4.37%, compared to CTTQF's ROE of +0.04%. Regarding short-term risk, URYL and CTTQF have similar daily volatility (0.00).Check CTTQF's competition here
URYL vs GRGSF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, GRGSF has a market cap of 894.6M. Regarding current trading prices, URYL is priced at $0.00, while GRGSF trades at $7.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas GRGSF's P/E ratio is -66.42. In terms of profitability, URYL's ROE is -4.37%, compared to GRGSF's ROE of -0.10%. Regarding short-term risk, URYL and GRGSF have similar daily volatility (0.00).Check GRGSF's competition here
URYL vs AAGRY Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, AAGRY has a market cap of 885.4M. Regarding current trading prices, URYL is priced at $0.00, while AAGRY trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas AAGRY's P/E ratio is 10.00. In terms of profitability, URYL's ROE is -4.37%, compared to AAGRY's ROE of +0.07%. Regarding short-term risk, URYL and AAGRY have similar daily volatility (0.00).Check AAGRY's competition here
URYL vs PTABF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, PTABF has a market cap of 844.7M. Regarding current trading prices, URYL is priced at $0.00, while PTABF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas PTABF's P/E ratio is 10.97. In terms of profitability, URYL's ROE is -4.37%, compared to PTABF's ROE of +0.07%. Regarding short-term risk, URYL and PTABF have similar daily volatility (0.00).Check PTABF's competition here
URYL vs AEPLF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, AEPLF has a market cap of 787.9M. Regarding current trading prices, URYL is priced at $0.00, while AEPLF trades at $20.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas AEPLF's P/E ratio is 8.89. In terms of profitability, URYL's ROE is -4.37%, compared to AEPLF's ROE of +0.16%. Regarding short-term risk, URYL and AEPLF have similar daily volatility (0.00).Check AEPLF's competition here
URYL vs EDESY Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, EDESY has a market cap of 729.1M. Regarding current trading prices, URYL is priced at $0.00, while EDESY trades at $19.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas EDESY's P/E ratio is 15.18. In terms of profitability, URYL's ROE is -4.37%, compared to EDESY's ROE of +0.05%. Regarding short-term risk, URYL and EDESY have similar daily volatility (0.00).Check EDESY's competition here
URYL vs MRVSY Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, MRVSY has a market cap of 728.2M. Regarding current trading prices, URYL is priced at $0.00, while MRVSY trades at $2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas MRVSY's P/E ratio is 7.97. In terms of profitability, URYL's ROE is -4.37%, compared to MRVSY's ROE of +0.54%. Regarding short-term risk, URYL and MRVSY have similar daily volatility (0.00).Check MRVSY's competition here
URYL vs GRCLF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, GRCLF has a market cap of 709.6M. Regarding current trading prices, URYL is priced at $0.00, while GRCLF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas GRCLF's P/E ratio is -80.00. In terms of profitability, URYL's ROE is -4.37%, compared to GRCLF's ROE of -0.01%. Regarding short-term risk, URYL and GRCLF have similar daily volatility (0.00).Check GRCLF's competition here
URYL vs PPLFY Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, PPLFY has a market cap of 662.9M. Regarding current trading prices, URYL is priced at $0.00, while PPLFY trades at $4.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas PPLFY's P/E ratio is 6.31. In terms of profitability, URYL's ROE is -4.37%, compared to PPLFY's ROE of +0.14%. Regarding short-term risk, URYL is less volatile compared to PPLFY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check PPLFY's competition here
URYL vs PPLFF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, PPLFF has a market cap of 585.7M. Regarding current trading prices, URYL is priced at $0.00, while PPLFF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas PPLFF's P/E ratio is 4.29. In terms of profitability, URYL's ROE is -4.37%, compared to PPLFF's ROE of +0.14%. Regarding short-term risk, URYL and PPLFF have similar daily volatility (0.00).Check PPLFF's competition here
URYL vs ORENF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, ORENF has a market cap of 579.4M. Regarding current trading prices, URYL is priced at $0.00, while ORENF trades at $5.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas ORENF's P/E ratio is 12.53. In terms of profitability, URYL's ROE is -4.37%, compared to ORENF's ROE of +0.09%. Regarding short-term risk, URYL and ORENF have similar daily volatility (0.00).Check ORENF's competition here
URYL vs AAYYY Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, AAYYY has a market cap of 579.3M. Regarding current trading prices, URYL is priced at $0.00, while AAYYY trades at $9.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas AAYYY's P/E ratio is 7.63. In terms of profitability, URYL's ROE is -4.37%, compared to AAYYY's ROE of +0.06%. Regarding short-term risk, URYL is less volatile compared to AAYYY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check AAYYY's competition here
URYL vs ASAGF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, ASAGF has a market cap of 551.3M. Regarding current trading prices, URYL is priced at $0.00, while ASAGF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas ASAGF's P/E ratio is 7.04. In terms of profitability, URYL's ROE is -4.37%, compared to ASAGF's ROE of +0.06%. Regarding short-term risk, URYL and ASAGF have similar daily volatility (0.00).Check ASAGF's competition here
URYL vs UVPOF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, UVPOF has a market cap of 497.3M. Regarding current trading prices, URYL is priced at $0.00, while UVPOF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas UVPOF's P/E ratio is 13.22. In terms of profitability, URYL's ROE is -4.37%, compared to UVPOF's ROE of +0.34%. Regarding short-term risk, URYL and UVPOF have similar daily volatility (0.00).Check UVPOF's competition here
URYL vs BRCPF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, BRCPF has a market cap of 441.1M. Regarding current trading prices, URYL is priced at $0.00, while BRCPF trades at $4.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas BRCPF's P/E ratio is 11.31. In terms of profitability, URYL's ROE is -4.37%, compared to BRCPF's ROE of -0.01%. Regarding short-term risk, URYL and BRCPF have similar daily volatility (0.00).Check BRCPF's competition here
URYL vs SLMCF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SLMCF has a market cap of 429.2M. Regarding current trading prices, URYL is priced at $0.00, while SLMCF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SLMCF's P/E ratio is 22.00. In terms of profitability, URYL's ROE is -4.37%, compared to SLMCF's ROE of -0.03%. Regarding short-term risk, URYL and SLMCF have similar daily volatility (0.00).Check SLMCF's competition here
URYL vs SLCJF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SLCJF has a market cap of 339.6M. Regarding current trading prices, URYL is priced at $0.00, while SLCJF trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SLCJF's P/E ratio is 7.82. In terms of profitability, URYL's ROE is -4.37%, compared to SLCJF's ROE of +0.10%. Regarding short-term risk, URYL and SLCJF have similar daily volatility (0.00).Check SLCJF's competition here
URYL vs SARDY Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SARDY has a market cap of 338.3M. Regarding current trading prices, URYL is priced at $0.00, while SARDY trades at $18.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SARDY's P/E ratio is 8.11. In terms of profitability, URYL's ROE is -4.37%, compared to SARDY's ROE of +0.10%. Regarding short-term risk, URYL and SARDY have similar daily volatility (0.00).Check SARDY's competition here
URYL vs SARDF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SARDF has a market cap of 327.3M. Regarding current trading prices, URYL is priced at $0.00, while SARDF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SARDF's P/E ratio is 8.97. In terms of profitability, URYL's ROE is -4.37%, compared to SARDF's ROE of +0.09%. Regarding short-term risk, URYL and SARDF have similar daily volatility (0.00).Check SARDF's competition here
URYL vs ALFDF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, ALFDF has a market cap of 284.7M. Regarding current trading prices, URYL is priced at $0.00, while ALFDF trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas ALFDF's P/E ratio is 9.35. In terms of profitability, URYL's ROE is -4.37%, compared to ALFDF's ROE of +0.15%. Regarding short-term risk, URYL and ALFDF have similar daily volatility (0.00).Check ALFDF's competition here
URYL vs SPZI Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SPZI has a market cap of 273.9M. Regarding current trading prices, URYL is priced at $0.00, while SPZI trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SPZI's P/E ratio is -43.00. In terms of profitability, URYL's ROE is -4.37%, compared to SPZI's ROE of N/A. Regarding short-term risk, URYL is less volatile compared to SPZI. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check SPZI's competition here
URYL vs DDEJF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, DDEJF has a market cap of 217.2M. Regarding current trading prices, URYL is priced at $0.00, while DDEJF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas DDEJF's P/E ratio is 1.18. In terms of profitability, URYL's ROE is -4.37%, compared to DDEJF's ROE of +0.59%. Regarding short-term risk, URYL is less volatile compared to DDEJF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check DDEJF's competition here
URYL vs STNT Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, STNT has a market cap of 162.5M. Regarding current trading prices, URYL is priced at $0.00, while STNT trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas STNT's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to STNT's ROE of +0.24%. Regarding short-term risk, URYL is less volatile compared to STNT. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check STNT's competition here
URYL vs DNDEF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, DNDEF has a market cap of 79.2M. Regarding current trading prices, URYL is priced at $0.00, while DNDEF trades at $15.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas DNDEF's P/E ratio is -38.66. In terms of profitability, URYL's ROE is -4.37%, compared to DNDEF's ROE of -0.12%. Regarding short-term risk, URYL is less volatile compared to DNDEF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check DNDEF's competition here
URYL vs NNUTU Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, NNUTU has a market cap of 41.6M. Regarding current trading prices, URYL is priced at $0.00, while NNUTU trades at $3,750.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas NNUTU's P/E ratio is 28.31. In terms of profitability, URYL's ROE is -4.37%, compared to NNUTU's ROE of N/A. Regarding short-term risk, URYL and NNUTU have similar daily volatility (0.00).Check NNUTU's competition here
URYL vs IDBHF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, IDBHF has a market cap of 30M. Regarding current trading prices, URYL is priced at $0.00, while IDBHF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas IDBHF's P/E ratio is 0.14. In terms of profitability, URYL's ROE is -4.37%, compared to IDBHF's ROE of +0.08%. Regarding short-term risk, URYL is less volatile compared to IDBHF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check IDBHF's competition here
URYL vs OPTHF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, OPTHF has a market cap of 22.8M. Regarding current trading prices, URYL is priced at $0.00, while OPTHF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas OPTHF's P/E ratio is -5.88. In terms of profitability, URYL's ROE is -4.37%, compared to OPTHF's ROE of -0.57%. Regarding short-term risk, URYL is less volatile compared to OPTHF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check OPTHF's competition here
URYL vs CTUNF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CTUNF has a market cap of 18.5M. Regarding current trading prices, URYL is priced at $0.00, while CTUNF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CTUNF's P/E ratio is -0.57. In terms of profitability, URYL's ROE is -4.37%, compared to CTUNF's ROE of -0.45%. Regarding short-term risk, URYL is less volatile compared to CTUNF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check CTUNF's competition here
URYL vs CLAD Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CLAD has a market cap of 15M. Regarding current trading prices, URYL is priced at $0.00, while CLAD trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CLAD's P/E ratio is -33.67. In terms of profitability, URYL's ROE is -4.37%, compared to CLAD's ROE of +0.04%. Regarding short-term risk, URYL is less volatile compared to CLAD. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check CLAD's competition here
URYL vs CMGHY Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CMGHY has a market cap of 14.6M. Regarding current trading prices, URYL is priced at $0.00, while CMGHY trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CMGHY's P/E ratio is -8.84. In terms of profitability, URYL's ROE is -4.37%, compared to CMGHY's ROE of -0.08%. Regarding short-term risk, URYL is less volatile compared to CMGHY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check CMGHY's competition here
URYL vs PRCF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, PRCF has a market cap of 12M. Regarding current trading prices, URYL is priced at $0.00, while PRCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas PRCF's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to PRCF's ROE of N/A. Regarding short-term risk, URYL is less volatile compared to PRCF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check PRCF's competition here
URYL vs PEASF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, PEASF has a market cap of 7.1M. Regarding current trading prices, URYL is priced at $0.00, while PEASF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas PEASF's P/E ratio is -1.56. In terms of profitability, URYL's ROE is -4.37%, compared to PEASF's ROE of -1.02%. Regarding short-term risk, URYL and PEASF have similar daily volatility (0.00).Check PEASF's competition here
URYL vs CMGHF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CMGHF has a market cap of 5.9M. Regarding current trading prices, URYL is priced at $0.00, while CMGHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CMGHF's P/E ratio is -1.78. In terms of profitability, URYL's ROE is -4.37%, compared to CMGHF's ROE of -0.10%. Regarding short-term risk, URYL and CMGHF have similar daily volatility (0.00).Check CMGHF's competition here
URYL vs IGPFF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, IGPFF has a market cap of 5.4M. Regarding current trading prices, URYL is priced at $0.00, while IGPFF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas IGPFF's P/E ratio is 35.35. In terms of profitability, URYL's ROE is -4.37%, compared to IGPFF's ROE of -0.39%. Regarding short-term risk, URYL is less volatile compared to IGPFF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check IGPFF's competition here
URYL vs MGNC Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, MGNC has a market cap of 5M. Regarding current trading prices, URYL is priced at $0.00, while MGNC trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas MGNC's P/E ratio is -20.00. In terms of profitability, URYL's ROE is -4.37%, compared to MGNC's ROE of -0.80%. Regarding short-term risk, URYL and MGNC have similar daily volatility (0.00).Check MGNC's competition here
URYL vs AASZF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, AASZF has a market cap of 4.9M. Regarding current trading prices, URYL is priced at $0.00, while AASZF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas AASZF's P/E ratio is -0.03. In terms of profitability, URYL's ROE is -4.37%, compared to AASZF's ROE of -2.17%. Regarding short-term risk, URYL is less volatile compared to AASZF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check AASZF's competition here
URYL vs HERB Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, HERB has a market cap of 4.7M. Regarding current trading prices, URYL is priced at $0.00, while HERB trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas HERB's P/E ratio is 0.03. In terms of profitability, URYL's ROE is -4.37%, compared to HERB's ROE of +0.03%. Regarding short-term risk, URYL and HERB have similar daily volatility (0.00).Check HERB's competition here
URYL vs GCEH Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, GCEH has a market cap of 1.8M. Regarding current trading prices, URYL is priced at $0.00, while GCEH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas GCEH's P/E ratio is 0.02. In terms of profitability, URYL's ROE is -4.37%, compared to GCEH's ROE of +3.01%. Regarding short-term risk, URYL is less volatile compared to GCEH. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check GCEH's competition here
URYL vs CAIHF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CAIHF has a market cap of 1.2M. Regarding current trading prices, URYL is priced at $0.00, while CAIHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CAIHF's P/E ratio is 0.02. In terms of profitability, URYL's ROE is -4.37%, compared to CAIHF's ROE of +0.11%. Regarding short-term risk, URYL and CAIHF have similar daily volatility (0.00).Check CAIHF's competition here
URYL vs RSSFF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, RSSFF has a market cap of 1.2M. Regarding current trading prices, URYL is priced at $0.00, while RSSFF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas RSSFF's P/E ratio is -1.22. In terms of profitability, URYL's ROE is -4.37%, compared to RSSFF's ROE of +1.23%. Regarding short-term risk, URYL and RSSFF have similar daily volatility (0.00).Check RSSFF's competition here
URYL vs GSFD Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, GSFD has a market cap of 933K. Regarding current trading prices, URYL is priced at $0.00, while GSFD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas GSFD's P/E ratio is -0.16. In terms of profitability, URYL's ROE is -4.37%, compared to GSFD's ROE of -0.05%. Regarding short-term risk, URYL and GSFD have similar daily volatility (0.00).Check GSFD's competition here
URYL vs PNDHF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, PNDHF has a market cap of 684.7K. Regarding current trading prices, URYL is priced at $0.00, while PNDHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas PNDHF's P/E ratio is -0.20. In terms of profitability, URYL's ROE is -4.37%, compared to PNDHF's ROE of +0.26%. Regarding short-term risk, URYL and PNDHF have similar daily volatility (0.00).Check PNDHF's competition here
URYL vs FLAF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, FLAF has a market cap of 460.4K. Regarding current trading prices, URYL is priced at $0.00, while FLAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas FLAF's P/E ratio is -0.01. In terms of profitability, URYL's ROE is -4.37%, compared to FLAF's ROE of -4.06%. Regarding short-term risk, URYL and FLAF have similar daily volatility (0.00).Check FLAF's competition here
URYL vs MSRM Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, MSRM has a market cap of 268.7K. Regarding current trading prices, URYL is priced at $0.00, while MSRM trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas MSRM's P/E ratio is -1.60. In terms of profitability, URYL's ROE is -4.37%, compared to MSRM's ROE of +2.80%. Regarding short-term risk, URYL is less volatile compared to MSRM. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check MSRM's competition here
URYL vs MSAH Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, MSAH has a market cap of 241.2K. Regarding current trading prices, URYL is priced at $0.00, while MSAH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas MSAH's P/E ratio is 0.17. In terms of profitability, URYL's ROE is -4.37%, compared to MSAH's ROE of +0.38%. Regarding short-term risk, URYL is less volatile compared to MSAH. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check MSAH's competition here
URYL vs HERF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, HERF has a market cap of 128.3K. Regarding current trading prices, URYL is priced at $0.00, while HERF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas HERF's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to HERF's ROE of +0.00%. Regarding short-term risk, URYL and HERF have similar daily volatility (0.00).Check HERF's competition here
URYL vs SHMP Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SHMP has a market cap of 127.8K. Regarding current trading prices, URYL is priced at $0.00, while SHMP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SHMP's P/E ratio is -0.01. In terms of profitability, URYL's ROE is -4.37%, compared to SHMP's ROE of +1.16%. Regarding short-term risk, URYL and SHMP have similar daily volatility (0.00).Check SHMP's competition here
URYL vs STEV Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, STEV has a market cap of 56.9K. Regarding current trading prices, URYL is priced at $0.00, while STEV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas STEV's P/E ratio is -0.01. In terms of profitability, URYL's ROE is -4.37%, compared to STEV's ROE of +0.02%. Regarding short-term risk, URYL is less volatile compared to STEV. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check STEV's competition here
URYL vs FLLLF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, FLLLF has a market cap of 51.8K. Regarding current trading prices, URYL is priced at $0.00, while FLLLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas FLLLF's P/E ratio is -0.28. In terms of profitability, URYL's ROE is -4.37%, compared to FLLLF's ROE of +0.23%. Regarding short-term risk, URYL and FLLLF have similar daily volatility (0.00).Check FLLLF's competition here
URYL vs SUWN Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SUWN has a market cap of 20K. Regarding current trading prices, URYL is priced at $0.00, while SUWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SUWN's P/E ratio is -0.00. In terms of profitability, URYL's ROE is -4.37%, compared to SUWN's ROE of -0.49%. Regarding short-term risk, URYL and SUWN have similar daily volatility (0.00).Check SUWN's competition here
URYL vs SIAF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SIAF has a market cap of 18.1K. Regarding current trading prices, URYL is priced at $0.00, while SIAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SIAF's P/E ratio is -0.00. In terms of profitability, URYL's ROE is -4.37%, compared to SIAF's ROE of -0.23%. Regarding short-term risk, URYL and SIAF have similar daily volatility (0.00).Check SIAF's competition here
URYL vs CHYI Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CHYI has a market cap of 13.7K. Regarding current trading prices, URYL is priced at $0.00, while CHYI trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CHYI's P/E ratio is -1.00. In terms of profitability, URYL's ROE is -4.37%, compared to CHYI's ROE of +14.52%. Regarding short-term risk, URYL and CHYI have similar daily volatility (0.00).Check CHYI's competition here
URYL vs OGAA Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, OGAA has a market cap of 9.3K. Regarding current trading prices, URYL is priced at $0.00, while OGAA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas OGAA's P/E ratio is -0.01. In terms of profitability, URYL's ROE is -4.37%, compared to OGAA's ROE of -2.82%. Regarding short-term risk, URYL and OGAA have similar daily volatility (0.00).Check OGAA's competition here
URYL vs HLKKF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, HLKKF has a market cap of 8.7K. Regarding current trading prices, URYL is priced at $0.00, while HLKKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas HLKKF's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to HLKKF's ROE of -10.09%. Regarding short-term risk, URYL and HLKKF have similar daily volatility (0.00).Check HLKKF's competition here
URYL vs TAER Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, TAER has a market cap of 5.7K. Regarding current trading prices, URYL is priced at $0.00, while TAER trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas TAER's P/E ratio is -0.02. In terms of profitability, URYL's ROE is -4.37%, compared to TAER's ROE of +0.44%. Regarding short-term risk, URYL is less volatile compared to TAER. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check TAER's competition here
URYL vs FFRMF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, FFRMF has a market cap of 1.7K. Regarding current trading prices, URYL is priced at $0.00, while FFRMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas FFRMF's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to FFRMF's ROE of -2.83%. Regarding short-term risk, URYL and FFRMF have similar daily volatility (0.00).Check FFRMF's competition here
URYL vs BIQIF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, BIQIF has a market cap of 1K. Regarding current trading prices, URYL is priced at $0.00, while BIQIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas BIQIF's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to BIQIF's ROE of +0.01%. Regarding short-term risk, URYL and BIQIF have similar daily volatility (0.00).Check BIQIF's competition here
URYL vs GLGLF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, GLGLF has a market cap of 384. Regarding current trading prices, URYL is priced at $0.00, while GLGLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas GLGLF's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to GLGLF's ROE of -0.10%. Regarding short-term risk, URYL and GLGLF have similar daily volatility (0.00).Check GLGLF's competition here
URYL vs URBF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, URBF has a market cap of 250. Regarding current trading prices, URYL is priced at $0.00, while URBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas URBF's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to URBF's ROE of -56.17%. Regarding short-term risk, URYL and URBF have similar daily volatility (0.00).Check URBF's competition here
URYL vs CFPI Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CFPI has a market cap of 192. Regarding current trading prices, URYL is priced at $0.00, while CFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CFPI's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to CFPI's ROE of +0.03%. Regarding short-term risk, URYL and CFPI have similar daily volatility (0.00).Check CFPI's competition here
URYL vs KALRQ Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, KALRQ has a market cap of 92. Regarding current trading prices, URYL is priced at $0.00, while KALRQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas KALRQ's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to KALRQ's ROE of -0.19%. Regarding short-term risk, URYL and KALRQ have similar daily volatility (0.00).Check KALRQ's competition here
URYL vs TSLLF Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, TSLLF has a market cap of 0. Regarding current trading prices, URYL is priced at $0.00, while TSLLF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas TSLLF's P/E ratio is 19.15. In terms of profitability, URYL's ROE is -4.37%, compared to TSLLF's ROE of N/A. Regarding short-term risk, URYL and TSLLF have similar daily volatility (0.00).Check TSLLF's competition here
URYL vs OCESP Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, OCESP has a market cap of 0. Regarding current trading prices, URYL is priced at $0.00, while OCESP trades at $16.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas OCESP's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to OCESP's ROE of N/A. Regarding short-term risk, URYL and OCESP have similar daily volatility (0.00).Check OCESP's competition here
URYL vs CAOX Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CAOX has a market cap of 0. Regarding current trading prices, URYL is priced at $0.00, while CAOX trades at $420.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CAOX's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to CAOX's ROE of N/A. Regarding short-term risk, URYL is less volatile compared to CAOX. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check CAOX's competition here
URYL vs BYIN Comparison June 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, BYIN has a market cap of 0. Regarding current trading prices, URYL is priced at $0.00, while BYIN trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas BYIN's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to BYIN's ROE of +0.32%. Regarding short-term risk, URYL and BYIN have similar daily volatility (0.00).Check BYIN's competition here